Actively Recruiting
Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus
Led by Dow University of Health Sciences · Updated on 2025-12-01
46
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Brief Summary (Lay Description) This research study is being conducted to understand whether treating gum disease (periodontitis) can help improve kidney health in patients who have type-2 diabetes mellitus (T2DM). Both diabetes and gum disease are common long-term conditions that often occur together. People with uncontrolled diabetes are at risk of developing kidney problems due to damage in the small blood vessels of the kidneys - a condition known as diabetic nephropathy. Scientific evidence has already shown that treating gum disease can help improve blood sugar control in diabetic patients. However, it is still unclear whether gum treatment can also help reduce the risk or severity of kidney-related complications. This study aims to find out if non-surgical periodontal therapy (NSPT), which includes scaling and root planing (deep dental cleaning), has any effect on blood markers of kidney function - specifically urea, creatinine, and estimated glomerular filtration rate (eGFR) - in patients with uncontrolled type-2 diabetes. The study will be conducted as a randomized controlled trial involving 46 patients with uncontrolled T2DM (HbA1c ≥ 7%) who also have moderate to severe gum disease. Participants will be divided randomly into two groups: Test Group: Will receive full-mouth non-surgical periodontal therapy (scaling and root planing) and oral hygiene instructions. Control Group: Will receive oral hygiene instructions only and will get the same gum treatment later (after 90 days, as delayed therapy). All participants will have their gum health examined, and blood tests will be done at the start and again after 90 days to measure urea, creatinine, and eGFR levels. These tests help determine how well the kidneys are working. The changes in these values before and after gum treatment will show whether improving oral health has any beneficial impact on kidney function in diabetics. The study is expected to take one year and will be conducted at Dow University of Health Sciences, Karachi. All participants will receive standard dental and laboratory assessments at no cost. The results may help improve future strategies for managing diabetic patients by integrating oral health care with medical care. Purpose: To determine whether treating gum disease (through non-surgical periodontal therapy) can improve kidney function markers - urea, creatinine, and eGFR - in patients with uncontrolled type-2 diabetes mellitus. Question being answered: Does non-surgical periodontal therapy have a positive effect on kidney function in uncontrolled type-2 diabetic patients by reducing urea and creatinine levels and improving eGFR?
CONDITIONS
Official Title
Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults between 30 and 65 years of age
- Men and women diagnosed with type 2 diabetes mellitus for at least one year
- Uncontrolled diabetes with HbA1c of 7% or higher
- Moderate to severe gum disease (Stage II or Stage III periodontitis)
- Estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m² or higher
- Able and willing to provide written informed consent
You will not qualify if you...
- Critically ill or unable to communicate effectively
- Pregnant or breastfeeding women
- Women using hormone replacement therapy or oral contraceptives in the past six months
- Use of steroidal, nonsteroidal anti-inflammatory drugs (NSAIDs), or other anti-inflammatory meds in past three months (except low-dose aspirin up to 75 mg daily)
- Recent history of major blood loss, trauma, or gastrointestinal bleeding
- Use of antibiotics within the last month
- History of fever or vomiting lasting more than one week within the last month
- Regular tobacco or alcohol users
- Presence of other chronic diseases or conditions that could affect study results
- Unwilling or unable to comply with study procedures or follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dow University of Health Scinces
Karachi, Sindh, Pakistan, 75330
Actively Recruiting
Research Team
M
Muhammad Ather Khan, BDS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here